Our Chairman of the Board of Directors, Nathan Imperiale, was recently invited by Philip Leider, President of the Board of the Sarcoma Alliance, to present about the Synovial Sarcoma Foundation in a live webinar hosted by the Sarcoma Alliance. The conversation covered the Foundation’s origin story, our active research programs, and the resources available to […]
Synovial Sarcoma of the Hyoid Bone: A Rare Case
A case report by Ryan Toledo, Jennifer Khong, and colleagues (published August 31, 2026; DOI: 10.7812/TPP/26.039) describes only the third known synovial sarcoma arising from the hyoid bone, a small U-shaped bone in the neck. The patient, a 62-year-old man, remains disease-free years after treatment. The Case The patient had a slowly growing left-sided neck […]
Two New TCR-NK Cell Therapy Trials Now Recruiting for Synovial Sarcoma
Two clinical trials testing TCR-NK cell therapy for advanced synovial sarcoma are now recruiting patients, one in the United States and one in the United Kingdom. Both use donor-derived natural killer cells engineered to target proteins commonly found on synovial sarcoma tumors. What Is TCR-NK Cell Therapy? TCR-NK therapy works differently from the TCR-T cell […]
Synovial Sarcoma Foundation Launches Ambassador Program During Childhood Cancer Awareness Month
New program invites patients, survivors, caregivers, and families to turn lived experience into advocacy. [Philadelphia, PA], September 1, 2026: This Childhood Cancer Awareness Month, the Synovial Sarcoma Foundation (SSF) is inviting patients, survivors, caregivers, and supporters to take their advocacy further. SSF has officially launched its Ambassador Program, an ongoing initiative for anyone connected to […]




